Hims & Hers’ stock rockets after teaming up with its rival Wegovy maker
Health and wellness company Hims & Hers, which sells alternatives to weight-loss drugs like Wegovy, is now collaborating with the maker of Wegovy.
Home-price growth fizzles as economic uncertainty weighs on home buyers
Home-price growth in the 20 biggest U.S. metropolitan areas is losing steam as buyers exit the housing market in the face of persistent…
GM’s stock slips as car giant updates guidance amid tariff impact
GM said its initial full-year 2025 guidance “does not contemplate the potential impact of tariffs.”
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
Why the stock market’s about to hit a wall, according to this strategist
Keith Lerner of Truist Advisory Services says the S&P 500’s upside is limited to 5% near-term, but the downside could be 10%.
This is the best way to help older homeowners
Property taxes can be a significant burden on older people. This proposal could help.
U.S. trade deficit in goods soars to all-time high as businesses aimed to beat Trump tariffs
U.S. businesses brought in a new high of foreign goods in March for the fourth month in a row as they tried to beat price increases tied to…
Another juicy S&P 500 target goes by the wayside as this 6,700 call is thrown into trash
HSBC on Tuesday slashed its target to 5,600 from 6,700, based on a forecast for slower U.S. growth, sticky inflation and falling bond yields.
Job openings in the U.S. fall to six-month low. Trade wars could further depress hiring.
The number of job openings in the U.S. fell in March to a six-month low just as some of the Trump administration’s tariffs began to kick in,…